• Title of article

    1-(4-Phenoxybenzyl) 5-Aminouracil Derivatives and Their Analogues – Novel Inhibitors of Human Adenovirus Replication

  • Author/Authors

    Nikitenko, N.A N.F. Gamaleya Federal National Research Center for Epidemiology and Microbiology, Moscow, Russia , Gureeva, E.S Volgograd State Medical University, Volgograd, Russia , Ozerov, A.A Volgograd State Medical University, Volgograd, Russia , Tukhvatulin, A.I Volgograd State Medical University, Volgograd, Russia , Izhaeva, F.M N.F. Gamaleya Federal National Research Center for Epidemiology and Microbiology, Moscow, Russia , Prassolov, V.S Engelhardt Institute of Molecular Biology - Russian Academy of Sciences, Moscow, Russia , Deryabin, P.G N.F. Gamaleya Federal National Research Center for Epidemiology and Microbiology, Moscow, Russia , Novikov, M.S Volgograd State Medical University, Volgograd, Russia , Logunov, D.Y N.F. Gamaleya Federal National Research Center for Epidemiology and Microbiology, Moscow, Russia

  • Pages
    7
  • From page
    58
  • To page
    64
  • Abstract
    Adenovirus infections are characterized by widespread distribution. The lack of causal therapy, which is effective in treating this group of diseases, explains the need for new therapeutic drugs. Notably, anti-adenovi-ral activity of [4-(phenoxy)benzyl]-5-(phenylamino)-6-azauracil, 1-[4-(phenoxy)benzyl]-5-(morpholino) uracil, 1-[4-(4-chlorophenoxy)benzyl]-5-(morpholino) uracil, and 1-[4-(4-fluorophenoxy)-benzyl]-5-(morpholino) uracil was observed.
  • Keywords
    inhibitors of adenovirus replication , adenovirus replication , 5-aminouracil derivatives , Human adenovirus
  • Journal title
    Acta Naturae
  • Serial Year
    2018
  • Record number

    2616122